BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2520459)

  • 1. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
    García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
    Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma.
    George SR; Kovacs K; Asa SL; Horvath E; Cross EG; Burrow GN
    Clin Endocrinol (Oxf); 1987 Apr; 26(4):395-405. PubMed ID: 2888549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
    Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro effects of bromocriptine on isolated pituitary adenoma cells. Ultrastructural and morphometrical studies.
    Saeger W; Thiel M; Caselitz J; Lüdecke DK
    Pathol Res Pract; 1985 Dec; 180(6):697-704. PubMed ID: 3832005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
    Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
    Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response to aminergic stimuli and biological behavior of growth hormone secreting pituitary adenomas.
    Fanghanel G; Larraza O; Villalobos M; Fanghanel L; Velasco M; Velasco F
    Can J Neurol Sci; 1990 Feb; 17(1):78-82. PubMed ID: 2107017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenomas producing growth hormone in acromegalic patients.
    Smallman LA; Dunn PJ; Curran RC; London DR
    J Clin Pathol; 1984 Apr; 37(4):382-9. PubMed ID: 6368603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study.
    Kurtkaya-Yapicier O; Scheithauer BW; Carney JA; Kovacs K; Horvath E; Stratakis CA; Vidal S; Vella A; Young WF; Atkinson JL; Lloyd RV; Kontogeorgos G
    Ultrastruct Pathol; 2002; 26(6):345-53. PubMed ID: 12537759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
    Nishioka H; Haraoka J; Akada K
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):768-72. PubMed ID: 14974920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A light and electron microscopical study of pituitary adenomas.
    Stefăneanu L; Taşcă C; Coculescu M
    Endocrinologie; 1981; 19(4):243-8. PubMed ID: 7323648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
    McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
    Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological effects of octreotide on growth hormone-producing pituitary adenomas.
    Ezzat S; Horvath E; Harris AG; Kovacs K
    J Clin Endocrinol Metab; 1994 Jul; 79(1):113-8. PubMed ID: 8027215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.
    Kawakita S; Asa SL; Kovacs K
    J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro.
    Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of pituitary adenomas on touch preparations assisted by immunocytochemistry.
    Kontogeorgos G; Bassiouka I; Giannou P; Vamvassakis E; Rologis D; Orphanidis G
    Acta Cytol; 1995; 39(2):141-52. PubMed ID: 7887060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse hemolytic plaque assay. Electron microscopic observation of plaque-forming single adenoma cells in GH producing adenomas.
    Yamada S; Aiba T; Hattori A; Suzuki T; Asa SL; Kovacs K
    Pathol Res Pract; 1991 Jun; 187(5):546-51. PubMed ID: 1923944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormone.
    Arita H; Kinoshita M; Oshino S; Kitamura T; Otsuki M; Kasayama S; Shimokawa T; Shimomura I; Yoshimine T; Saitoh Y
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2741-7. PubMed ID: 22569237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.